Results 261 to 270 of about 425,993 (391)

Long-Term Benefits Following Hepatitis C Cure Through Facilitated Telemedicine; Experiences of People With Opioid use Disorder Five Years After Achieving a Sustained Virological Response. [PDF]

Health Expect
Papalamprakopoulou Z, Dang TH, Gonzalez CJ, Tedesco CJ, Updike PF, Corl C, Dharia A, Hernandez N, Shapiro MF, Wethington E, Talal AH.   +10 more
europepmc   +1 more source

Sofosbuvir and ribavirin in HCV genotypes 2 and 3.

New England Journal of Medicine, 2014
S. Zeuzem, G. Dusheiko, R. Salupere, A. Mangia, R. Flisiak, R. Hyland, A. Illeperuma, E. Svarovskaia, D. Brainard, W. Symonds, G. Subramanian, J. Mchutchison, O. Weiland, H. Reesink, P. Ferenci, C. Hézode, R. Esteban   +16 more
semanticscholar   +1 more source

Higher afamin concentrations are associated with higher fatty liver indices: Population‐based KORA F4/FF4 study

European Journal of Clinical Investigation, EarlyView.
The present study aimed to investigate the associations between afamin and fatty liver and fibrosis indices and to study potential modifying effects of sex and glucose tolerance status on these associations in individuals from the population‐based KORA F4/FF4 cohort.
Corinna Niersmann, Anna Zhu, Haifa Maalmi, Xinting Cai, Jana Nano, Wolfgang Rathmann, Wolfgang Koenig, Toshinari Takamura, Barbara Kollerits, Hans Dieplinger, Annette Peters, Michael Roden, Florian Kronenberg, Barbara Thorand, Christian Herder   +14 more
wiley   +1 more source

Silent mutations in coding regions of Hepatitis C virus affect patterns of HCV RNA structures and attenuate viral replication and pathogenesis. [PDF]

Genome Biol
Dabour R, Bergman S, Zafrir Z, Davidovitch A, Werbner M, Gal-Tanamy M, Tuller T.   +6 more
europepmc   +1 more source

A Study of HCV-Antibody Examination in MHTS

, 1994
清水 敏朗, 成田 登喜子, 安田 敬子, 神坂 和明, 鈴木 豊明   +4 more
openalex   +2 more sources

Daclatasvir plus Sofosbuvir for HCV in Patients Coinfected with HIV-1.

New England Journal of Medicine, 2015
D. Wyles, P. Ruane, M. Sulkowski, D. Dieterich, A. Luetkemeyer, T. Morgan, K. Sherman, R. Dretler, D. Fishbein, J. Gathe, S. Henn, F. Hinestrosa, C. Huynh, Cheryl Mcdonald, A. Mills, E. Overton, M. Ramgopal, B. Rashbaum, G. Ray, A. Scarsella, J. Yozviak, F. Mcphee, Zhaohui Liu, E. Hughes, P. Yin, S. Noviello, Peter Ackerman   +26 more
semanticscholar   +1 more source

Metabolic dysfunction‐associated steatotic liver disease, insulin resistance and hepatocellular carcinoma: A deadly triad

European Journal of Clinical Investigation, EarlyView.
Metabolic dysfunction‐associated steatotic liver disease (MASLD) is a major global cause of liver disease, driven by obesity and insulin resistance (IR). IR promotes hepatic lipid accumulation, inflammation and mitochondrial dysfunction, accelerating MASLD progression to fibrosis, cirrhosis and hepatocellular carcinoma (HCC).
Alfredo Caturano, Enes Erul, Roberto Nilo, Davide Nilo, Vincenzo Russo, Luca Rinaldi, Carlo Acierno, Erman Akkus, Katerina Koudelkova, Federica Cerini, Alessandro Rizzo, Ferdinando Carlo Sasso, Leonilde Bonfrate, Antonio Giordano, Hatime Arzu Yaşar, Caterina Conte   +15 more
wiley   +1 more source

Steatotic liver disease in chronic hepatitis C related hepatocellular carcinoma: Inflictor or bystander?: Correspondence to editorial on “Dynamic change of metabolic dysfunction-associated steatotic liver disease in chronic hepatitis C patients after viral eradication: A nationwide registry study in Taiwan” [PDF]

Clinical and Molecular Hepatology
Chung-Feng Huang, Ming-Lun Yeh, Chia-Yen Dai, Jee-Fu Huang, Wan-Long Chuang, Ming-Lung Yu   +5 more
doaj   +1 more source

Calcium Intake and Bone Mineral Density in People With HIV and/or Chronic Hepatitis C. [PDF]

Open Forum Infect Dis
Temesgen ZB, Temesgen Z, Bedimo RJ.
europepmc   +1 more source

C型慢性肝疾患における各種HCV抗体および尿中Neopterin測定の臨床的有用性に関する検討

, 1994

openalex   +2 more sources